Skip to main content
Caplight Logo









Laronix

Laronix

Private
BrisbaneHealthcare & Life Scienceshttps://www.laronix.com/

Last Round

Grant

Nov 12, 2025

Total Funding Raised

$577,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Laronix is a medical technology company that develops non-invasive, AI-powered voice restoration devices for individuals suffering from permanent or acute voice loss.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, NLP & Conversational AI

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

artificial larynxvoice restorationlaryngectomywearable medical devicespeech synthesisassistive technologyelectrolarynxvoice prosthesisbionic voicespeech-language pathologyotolaryngologymedtechhealth iotai voicevocal cord replacement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Laronix Comparables

Compare Laronix with similar companies based on industry and business-model similarity.

Laronix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Altavo
85%
Labex Trade Ltd.
83%
UltraVoice, Ltd.
79%

Laronix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 12, 2025
VC RoundAug 31, 2023
GrantAug 25, 2021
SeedSep 1, 2020

Key People

Founding team and executive leadership

Mousa Ahmadi

Chief Operating Officer Co-Founder

Founding Team

Laronix Investors

Notable investors and investment history

Laronix investors
InvestorRounds
Scale InvestorsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 23, 2026

    Grew 19% QoQ, from 16 to 19 employees.

  • Apr 20, 2026

    Monthly visitors increased 31% MoM, reaching 1.7K.

Laronix Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Laronix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Laronix's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrisbane
Employee Range14
Year Founded2018
Last FundingNov 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?